Investigation Overview
According to a press release there is currently an ongoing investigation on behalf of former and current employees of KV Pharmaceutical Company (NYSE: KV-A, KV-B, and KVPHP) concerning potential Employee Retirement Income Security Act (ERISA) Breach of Fiduciary Duty. According to the press release KV Pharmaceutical Company has been accused of securities fraud and under ERISA employe...
You must register (for free) or login to view the entire investigation.